Learn More
OBJECTIVES The purpose of this study was to characterise the plasma protein binding of BI 1356. METHODS BI 1356 (proposed trade name ONDERO) is a novel dipeptidyl peptidase 4 (DPP-4) inhibitor,(More)
In view of the increasing interest in the biological activity of resveratrol, one of the components of red wine which is considered to be one of the main ingredients responsible for the beneficial(More)